Related stories
EU Approves AstraZeneca’s Klygefa
The EU approved AstraZeneca’s Klygefa (gefurulimab).
M impact | REGULATION | Nov 16, 2026, 07:19 AM UTC
EU Recommends Baxfendy for Approval
Baxfendy has been recommended for approval in the EU.
M impact | REGULATION | Nov 16, 2026, 07:15 AM UTC
FDA approves AstraZeneca’s Imfinzi plus EV for bladder cancer
AstraZeneca said its Imfinzi plus EV regimen has been approved in the US for bladder cancer.
M impact | REGULATION | Nov 16, 2026, 07:10 AM UTC
AstraZeneca’s Klygefa Approved in US for Adult gMG Treatment
The approval was supported by PREVAIL Phase III results showing statistically significant results; the body text is truncated.
M impact | REGULATION | Nov 16, 2026, 07:06 AM UTC
AstraZeneca’s Klygefa Approved in the US
AstraZeneca said Klygefa (gefurulimab) was approved in the US.
M impact | REGULATION | Nov 16, 2026, 07:05 AM UTC
EU Aims to Mobilize €30 Billion for AI Investment via InvestAI
The EU aims to mobilize €30 billion for AI investment via InvestAI.
M impact | REGULATION | Nov 16, 2026, 07:01 AM UTC